Ongoing research with support from ABBAA.

Reading time: 4 min
WhatsApp ↗
Institutional · 30 Years of Social Allergology

Ongoing research with support from ABBAA.

✔ Medical and scientific content reviewed and validated. by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Clinical Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

"Recognized as a public utility organization in accordance with Municipal Law 3393 of March 25, 2024, in the municipality of Duque de Caxias, Rio de Janeiro."

Swine flu (H1N1 infection)

An autoimmune endocrine condition in pregnant women. Featuring the founders of Brazil Without Allergies.



Rapid test using CRISPR technology for COVID-19 detection.

Development of a quick and simple test to detect COVID-19 variants that can be used in remote areas and developing countries.


Treatment and Prevention of early-onset Alzheimer's disease using CRISPR/CAS9 technology (app modification via base editing using the CRISPR/CAS9 system) United States Patent and Trademark Office - Reference number 62/783,573 (Also filed with the INPI in Brazil and the Canadian Intellectual Property Office)

Ongoing research with support from ABBAA.

Development of a web course on gene therapy by the international consortium of gene therapy

 

 Support Professor Jacques P. Tremblay's gene therapy research.

COVID-19 TEST USING CRISPR TECHNOLOGY

Watch the video for information about the research supported by ABBAA.

 

YouTube video player

 "Recognized as a public utility organization in accordance with Municipal Law 3393 of March 25, 2024, in the municipality of Duque de Caxias, Rio de Janeiro."